$32.24
-0.64-1.95%
al cierre: Nov 13, 4:00 PM EST
$32.24
-0.64-1.95%
Premercado: 7:55 AM EST

The average analyst price target for SpyGlass Pharma is $45.83, 42.2% above the current price. Of 6 analysts, 6 rate it Buy. Targets range from $39 to $62. The latest change came on Nov 13, 2026, when Citigroup raised its price target on SpyGlass Pharma from $42 to $45 and kept a Buy rating.
Price Target Range — 3 Quarters
Analyst Consensus — 6 Analysts
Rating Trend — Last 9 Months